Author Affiliation: National Human Genome Research Institute, Bethesda, Maryland.
Few medications have received as much public scrutiny as those used for attention-deficit/hyperactivity disorder (ADHD). The most serious concerns have centered on cardiovascular risk. The study by Habel and colleagues1 in this issue of JAMA compared approximately150 000 adults prescribed ADHD medication with approximately 300 000 nonusers and found no evidence of a link between ADHD medications and myocardial infarction, sudden cardiac death, or stroke.
Shaw P. ADHD Medications and Cardiovascular Risk: Some Heartening News. JAMA. 2011;306(24):2723–2724. doi:10.1001/jama.2011.1866
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: